Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

2 filings reported holding INZY - Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share as of Q4 2023.
Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 57.9K shares of 64.5M outstanding shares and own 0.09% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (5.54M shares), Pivotal bioVenture Partners Investment Advisor LLC (4.49M shares), Sofinnova Investments, Inc. (4.28M shares), Rock Springs Capital Management LP (3.68M shares), SAMLYN CAPITAL, LLC (3.37M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.18M shares), BlackRock Inc. (3.04M shares), NEA Management Company, LLC (2.44M shares), VANGUARD GROUP INC (2.39M shares), and FMR LLC (2.27M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.